lidocaine has been researched along with Cardiomyopathy, Congestive in 13 studies
Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.
Excerpt | Relevance | Reference |
---|---|---|
"The electrophysiological and haemodynamic effects of lidocaine (100 mg) and ajmaline (50 mg) were evaluated while attempting to interrupt sustained ventricular tachycardia." | 9.07 | Electrophysiological and haemodynamic effects of lidocaine and ajmaline in the management of sustained ventricular tachycardia. ( Jung, W; Lüderitz, B; Manz, M; Mletzko, R, 1992) |
"The electrophysiological and haemodynamic effects of lidocaine (100 mg) and ajmaline (50 mg) were evaluated while attempting to interrupt sustained ventricular tachycardia." | 5.07 | Electrophysiological and haemodynamic effects of lidocaine and ajmaline in the management of sustained ventricular tachycardia. ( Jung, W; Lüderitz, B; Manz, M; Mletzko, R, 1992) |
"A patient with a dilated cardiomyopathy experienced a cardiac arrest when taking tocainide for asymptomatic nonsustained ventricular tachycardia." | 3.67 | Possible proarrhythmic effects of tocainide in dilated cardiomyopathy. ( Brownstein, SL; Constantin, L; Kienzle, MG; Martins, JB, 1988) |
"Thirty-nine consecutive patients with dilated cardiomyopathy and severe HF with a left ventricular ejection fraction < 35% were randomly divided into 2 groups: control group (n = 16, 12 males and 4 females, aged 56 +/- 16, undergoing routine anti-HF treatment), and cardiac sympathetic blockade (TEB) group (n = 23, 18 males and 5 females, aged 51 +/- 13, undergoing sympathectomy at the interspinal space T3 - 4 or T4 - 5 in addition to the routine anti-HF treatment)." | 2.72 | [Effects of cardiac sympathetic blockade on left ventricular diastolic function in patients with dilated cardiomyopathy and severe heart failure]. ( Liu, FQ; Qu, RH; Wang, HQ; Wang, X; Xiu, CH, 2006) |
"0." | 1.46 | Thoracic Epidural Anesthesia Reversed Myocardial Fibrosis in Patients With Heart Failure Caused by Dilated Cardiomyopathy. ( Li, L; Liu, F; Liu, L; Liu, P; Ma, D; Qu, R; Wang, Y; Yun, F; Zhang, R; Zhao, H, 2017) |
"Ranolazine is a drug that exerts antianginal and antiischemic effects and also acts as an antiarrhythmic in isolation and in combination with other class III medications." | 1.37 | Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocks. ( Anderson, JL; Bair, TL; Bunch, TJ; Crandall, BG; Day, JD; Lappe, DL; Mader, KM; Mahapatra, S; May, HT; Molden, J; Muhlestein, JB; Murdock, D; Osborn, JS; Weiss, JP, 2011) |
"Our objective was to elucidate the mechanism of pharmacokinetic interaction between lidocaine and mexiletine, because an unexpected increase in plasma lidocaine concentration accompanied by severe side effects was observed when mexiletine was administered to a patient with dilated cardiomyopathy." | 1.31 | Possible mechanism for pharmacokinetic interaction between lidocaine and mexiletine. ( Fukuzawa, M; Funakoshi, S; Kugaya, Y; Maeda, Y; Murakami, T; Nakamura, M; Takano, M; Tsukiai, S; Yamasaki, M, 2002) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (30.77) | 18.7374 |
1990's | 4 (30.77) | 18.2507 |
2000's | 2 (15.38) | 29.6817 |
2010's | 3 (23.08) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ma, D | 1 |
Liu, L | 1 |
Zhao, H | 1 |
Zhang, R | 1 |
Yun, F | 1 |
Li, L | 1 |
Wang, Y | 1 |
Qu, R | 1 |
Liu, P | 1 |
Liu, F | 1 |
Bunch, TJ | 1 |
Mahapatra, S | 1 |
Murdock, D | 1 |
Molden, J | 1 |
Weiss, JP | 1 |
May, HT | 1 |
Bair, TL | 1 |
Mader, KM | 1 |
Crandall, BG | 1 |
Day, JD | 1 |
Osborn, JS | 1 |
Muhlestein, JB | 1 |
Lappe, DL | 1 |
Anderson, JL | 1 |
Farid, TA | 1 |
Nair, K | 1 |
Massé, S | 1 |
Azam, MA | 1 |
Maguy, A | 1 |
Lai, PF | 1 |
Umapathy, K | 1 |
Dorian, P | 1 |
Chauhan, V | 1 |
Varró, A | 1 |
Al-Hesayen, A | 1 |
Waxman, M | 1 |
Nattel, S | 1 |
Nanthakumar, K | 1 |
Xiu, CH | 1 |
Liu, FQ | 1 |
Wang, HQ | 1 |
Wang, X | 1 |
Qu, RH | 1 |
Schechter, WS | 1 |
Kim, C | 1 |
Martinez, M | 1 |
Gleason, BF | 1 |
Lund, DP | 1 |
Burrows, FA | 1 |
Maeda, Y | 1 |
Funakoshi, S | 1 |
Nakamura, M | 1 |
Fukuzawa, M | 1 |
Kugaya, Y | 1 |
Yamasaki, M | 1 |
Tsukiai, S | 1 |
Murakami, T | 1 |
Takano, M | 1 |
Geraets, DR | 1 |
Scott, SD | 1 |
Ballew, KA | 1 |
Manz, M | 1 |
Mletzko, R | 1 |
Jung, W | 1 |
Lüderitz, B | 1 |
Breen, TW | 1 |
Janzen, JA | 1 |
Brownstein, SL | 1 |
Constantin, L | 1 |
Kienzle, MG | 1 |
Martins, JB | 1 |
Goedel-Meinen, L | 1 |
Hofmann, M | 1 |
Schmidt, G | 1 |
Barthel, P | 1 |
Baedeker, W | 1 |
Blömer, H | 1 |
Gambling, DR | 1 |
Flanagan, ML | 1 |
Huckell, VF | 1 |
Lucas, SB | 1 |
Kim, JH | 1 |
Halinen, MO | 1 |
3 trials available for lidocaine and Cardiomyopathy, Congestive
Article | Year |
---|---|
[Effects of cardiac sympathetic blockade on left ventricular diastolic function in patients with dilated cardiomyopathy and severe heart failure].
Topics: Adult; Aged; Autonomic Nerve Block; Cardiomyopathy, Dilated; Female; Heart; Heart Failure; Humans; L | 2006 |
Electrophysiological and haemodynamic effects of lidocaine and ajmaline in the management of sustained ventricular tachycardia.
Topics: Ajmaline; Cardiac Output; Cardiac Pacing, Artificial; Cardiomyopathy, Dilated; Coronary Disease; Ele | 1992 |
[Effect of class I anti-arrhythmia agents on the signal-averaged ECG].
Topics: Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Clinical Trials as Topic; Coronary Disease; Disopyr | 1988 |
10 other studies available for lidocaine and Cardiomyopathy, Congestive
Article | Year |
---|---|
Thoracic Epidural Anesthesia Reversed Myocardial Fibrosis in Patients With Heart Failure Caused by Dilated Cardiomyopathy.
Topics: Aged; Anesthesia, Epidural; Anesthetics, Local; Cardiomyopathy, Dilated; Cohort Studies; Female; Fib | 2017 |
Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocks.
Topics: Acetanilides; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Cohort Studies; Def | 2011 |
Role of KATP channels in the maintenance of ventricular fibrillation in cardiomyopathic human hearts.
Topics: Action Potentials; Animals; Cardiomyopathy, Dilated; Endocardium; Glyburide; Humans; In Vitro Techni | 2011 |
Anaesthetic induction in a child with end-stage cardiomyopathy.
Topics: Anesthesia, Intravenous; Cardiomyopathy, Dilated; Child; Enteral Nutrition; Etomidate; Gastroscopy; | 1995 |
Possible mechanism for pharmacokinetic interaction between lidocaine and mexiletine.
Topics: Aged; Aged, 80 and over; Animals; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Drug Interactions | 2002 |
Toxicity potential of oral lidocaine in a patient receiving mexiletine.
Topics: Administration, Oral; Cardiomyopathy, Dilated; Central Nervous System; Female; Humans; Lidocaine; Me | 1992 |
Pulmonary hypertension and cardiomyopathy: anaesthetic management for caesarean section.
Topics: Adolescent; Anesthesia, Epidural; Anesthesia, Obstetrical; Cardiomyopathy, Dilated; Cesarean Section | 1991 |
Possible proarrhythmic effects of tocainide in dilated cardiomyopathy.
Topics: Cardiomyopathy, Dilated; Heart Arrest; Humans; Lidocaine; Male; Middle Aged; Tachycardia; Tocainide | 1988 |
Anaesthetic management and non-invasive monitoring for caesarean section in a patient with cardiomyopathy.
Topics: Adult; Anesthesia, Epidural; Anesthesia, Obstetrical; Cardiomyopathy, Dilated; Cesarean Section; Fem | 1987 |
[Management of ventricular arrhythmias].
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Electrocardiography; Humans; | 1986 |